Nolato AB (publ) (NOLA-B) - Total Assets
Based on the latest financial reports, Nolato AB (publ) (NOLA-B) holds total assets worth Skr9.28 Billion SEK (≈ $998.89 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Nolato AB (publ) (NOLA-B) net assets for net asset value and shareholders' equity analysis.
Nolato AB (publ) - Total Assets Trend (2002–2025)
This chart illustrates how Nolato AB (publ)'s total assets have evolved over time, based on quarterly financial data.
Nolato AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2025)
Nolato AB (publ)'s total assets of Skr9.28 Billion consist of 40.1% current assets and 59.9% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr482.00 Million | 5.2% |
| Accounts Receivable | Skr1.60 Billion | 17.2% |
| Inventory | Skr1.09 Billion | 11.7% |
| Property, Plant & Equipment | Skr3.36 Billion | 36.2% |
| Intangible Assets | Skr2.17 Billion | 23.4% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2002–2025)
This chart illustrates how Nolato AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Nolato AB (publ) (NOLA-B) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nolato AB (publ)'s current assets represent 40.1% of total assets in 2025, a decrease from 50.8% in 2002.
- Cash Position: Cash and equivalents constituted 5.2% of total assets in 2025, down from 9.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 4.0% in 2002.
- Asset Diversification: The largest asset category is property, plant & equipment at 36.2% of total assets.
Nolato AB (publ) Competitors by Total Assets
Key competitors of Nolato AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Sino Medical Sciences Technology In
SHG:688108
|
China | CN¥1.34 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$127.41 Million |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.75 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.00 Billion |
|
Respiri Ltd
AU:RSH
|
Australia | AU$7.08 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Atomo Diagnostics Ltd
AU:AT1
|
Australia | AU$9.48 Million |
Nolato AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.73 | 2.00 | 1.33 |
| Quick Ratio | 1.22 | 1.38 | 0.97 |
| Cash Ratio | 0.22 | 0.35 | 0.00 |
| Working Capital | Skr1.57 Billion | Skr1.92 Billion | Skr1.16 Billion |
Nolato AB (publ) - Advanced Valuation Insights
This section examines the relationship between Nolato AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.49 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | -4.2% |
| Total Assets | Skr9.28 Billion |
| Market Capitalization | $1.29 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Nolato AB (publ)'s assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Nolato AB (publ)'s assets decreased by 4.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Nolato AB (publ) (2002–2025)
The table below shows the annual total assets of Nolato AB (publ) from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr9.28 Billion ≈ $998.89 Million |
-4.19% |
| 2024-12-31 | Skr9.69 Billion ≈ $1.04 Billion |
+4.17% |
| 2023-12-31 | Skr9.30 Billion ≈ $1.00 Billion |
-7.07% |
| 2022-12-31 | Skr10.01 Billion ≈ $1.08 Billion |
-0.48% |
| 2021-12-31 | Skr10.05 Billion ≈ $1.08 Billion |
+15.79% |
| 2020-12-31 | Skr8.68 Billion ≈ $934.54 Million |
+41.57% |
| 2019-12-31 | Skr6.13 Billion ≈ $660.12 Million |
+18.97% |
| 2018-12-31 | Skr5.16 Billion ≈ $554.87 Million |
+8.50% |
| 2017-12-31 | Skr4.75 Billion ≈ $511.39 Million |
+21.10% |
| 2016-12-31 | Skr3.92 Billion ≈ $422.29 Million |
+21.37% |
| 2015-12-31 | Skr3.23 Billion ≈ $347.92 Million |
+10.95% |
| 2014-12-31 | Skr2.91 Billion ≈ $313.59 Million |
+13.25% |
| 2013-12-31 | Skr2.57 Billion ≈ $276.90 Million |
-2.32% |
| 2012-12-31 | Skr2.63 Billion ≈ $283.46 Million |
+22.85% |
| 2011-12-31 | Skr2.14 Billion ≈ $230.73 Million |
-8.77% |
| 2010-12-31 | Skr2.35 Billion ≈ $252.90 Million |
+11.22% |
| 2009-12-31 | Skr2.11 Billion ≈ $227.39 Million |
-0.61% |
| 2008-12-31 | Skr2.13 Billion ≈ $228.79 Million |
+10.84% |
| 2007-12-31 | Skr1.92 Billion ≈ $206.41 Million |
+11.25% |
| 2006-12-31 | Skr1.72 Billion ≈ $185.53 Million |
+3.36% |
| 2005-12-31 | Skr1.67 Billion ≈ $179.50 Million |
+4.38% |
| 2004-12-31 | Skr1.60 Billion ≈ $171.97 Million |
-12.92% |
| 2003-12-31 | Skr1.83 Billion ≈ $197.48 Million |
-3.17% |
| 2002-12-31 | Skr1.90 Billion ≈ $203.93 Million |
-- |
About Nolato AB (publ)
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more